ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 38 filers reported holding ORAMED PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $150,289 | -75.4% | 68,940 | -27.0% | 0.01% | -75.0% |
| Q3 2022 | $612,000 | +55.7% | 94,493 | +8.2% | 0.02% | +81.8% |
| Q2 2022 | $393,000 | -11.7% | 87,365 | +77.3% | 0.01% | +22.2% |
| Q1 2022 | $445,000 | -39.0% | 49,289 | -7.3% | 0.01% | -35.7% |
| Q4 2021 | $729,000 | -34.6% | 53,153 | +6.5% | 0.01% | -33.3% |
| Q3 2021 | $1,115,000 | +56.2% | 49,924 | -6.4% | 0.02% | +75.0% |
| Q2 2021 | $714,000 | +180.0% | 53,364 | -45.8% | 0.01% | +50.0% |
| Q3 2020 | $255,000 | -19.6% | 98,486 | +8.4% | 0.01% | -27.3% |
| Q2 2020 | $317,000 | +268.6% | 90,825 | +573.9% | 0.01% | +120.0% |
| Q1 2018 | $86,000 | -15.7% | 13,478 | +20.0% | 0.01% | -28.6% |
| Q4 2017 | $102,000 | +9.7% | 11,234 | +19.0% | 0.01% | -12.5% |
| Q3 2017 | $93,000 | +34.8% | 9,442 | +6.8% | 0.01% | +33.3% |
| Q2 2017 | $69,000 | – | 8,838 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 681,500 | $2,481,000 | 1.19% |
| DAFNA Capital Management LLC | 26,000 | $95,000 | 0.04% |
| Rossmore Private Capital | 15,061 | $55,000 | 0.02% |
| Sterling Investment Advisors, Ltd. | 3,150 | $11,000 | 0.01% |
| Close Asset Management Ltd | 7,500 | $27,000 | 0.00% |
| SeaCrest Wealth Management, LLC | 1,500 | $5,000 | 0.00% |
| JFS WEALTH ADVISORS, LLC | 500 | $2,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,506 | $5,000 | 0.00% |
| MORGAN STANLEY | 26,701 | $97,000 | 0.00% |
| BANK OF MONTREAL /CAN/ | 1,600 | $6,000 | 0.00% |